Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
Suwarti S, Lazarus G, Zanjabila S, Sinto R, Fransiska F, Deborah T, Oktavia D, Junaidah J, Santayana S, Surendra H, Yuliana J, Pardosi H, Nuraeni N, Soebianto S, Susilowati ND, Subekti D, Pradipta A, Baird JK, Tan LV, Dunachie S, Shankar AH, Nelwan EJ, Hamers RL; SEACOVARIANTS Consortium. Suwarti S, et al. Among authors: sinto r. BMC Infect Dis. 2024 Aug 1;24(1):768. doi: 10.1186/s12879-024-09644-y. BMC Infect Dis. 2024. PMID: 39090537 Free PMC article.
Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
Sinto R, Lie KC, Setiati S, Suwarto S, Nelwan EJ, Djumaryo DH, Karyanti MR, Prayitno A, Sumariyono S, Moore CE, Hamers RL, Day NPJ, Limmathurotsakul D. Sinto R, et al. Antimicrob Resist Infect Control. 2022 May 19;11(1):73. doi: 10.1186/s13756-022-01114-x. Antimicrob Resist Infect Control. 2022. PMID: 35590391 Free PMC article.
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2-Exposed CoronaVac-Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study.
Sinto R, Utomo D; Suwarti; Nelwan EJ, Surendra H, Natasha C; Fransiska; Theresia D, Ranitria AF, Subekti D, Nuraeni N, Handayani W, Rahardjani M, Baird JK, Dunachie S, Shankar AH, Hamers RL. Sinto R, et al. Am J Trop Med Hyg. 2022 Nov 30;108(1):115-123. doi: 10.4269/ajtmh.22-0256. Print 2023 Jan 11. Am J Trop Med Hyg. 2022. PMID: 36450232 Free PMC article.
Revisiting the Overlooked Infection: Rickettsioses.
Lie KC, Nelwan EJ, Pasaribu A, Shakinah S, Sinto R, Nainggolan L. Lie KC, et al. Among authors: sinto r. Acta Med Indones. 2022 Oct;54(4):647-652. Acta Med Indones. 2022. PMID: 36624720 Free article.
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia.
Fadlyana E, Setiabudi D, Kartasasmita CB, Putri ND, Rezeki Hadinegoro S, Mulholland K; BCOV21 study group. Fadlyana E, et al. Lancet Infect Dis. 2023 May;23(5):545-555. doi: 10.1016/S1473-3099(22)00800-3. Epub 2023 Jan 11. Lancet Infect Dis. 2023. PMID: 36640798 Clinical Trial.
53 results